Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency
Daniele Focosi, Massimo Franchini
Topics & Concepts
Convalescent plasmaCoronavirus disease 2019 (COVID-19)PotencySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Residual riskNeutralizing antibodyPathogen2019-20 coronavirus outbreakImmunologyAntibodyMedicineVirologyDiseaseBiologyInternal medicineInfectious disease (medical specialty)In vitroBiochemistryOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Outbreaks Research